1,425 results on '"Garcia-Tsao, Guadalupe"'
Search Results
52. Screening and Surveillance of Varices in Patients With Cirrhosis
53. The effect of endoscopic gastric plication on portosystemic pressure gradient in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease.
54. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage.
55. P20 Determining Clinically Meaningful Difference in Baseline EncephalApp Stroop Values to Predict HE-Related Outcomes With Multi-Center Validation
56. Controversies regarding albumin therapy in cirrhosis
57. The effect of endoscopic gastric plication on portosystemic pressure gradient in patients with nonalcoholic fatty liver disease and compensated advanced chronic liver disease
58. Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis
59. Future Pharmacological Therapies of Portal Hypertension
60. P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY
61. P-19 CHARACTERIZATION, PROGNOSTIC FACTORS, AND SURVIVAL IN MODERATE ALCOHOL-ASSOCIATED HEPATITIS: A MULTICENTER STUDY
62. CHAPTER 1 - Introduction
63. 139 - Cirrhosis and Its Sequelae
64. AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage
65. Prognostic significance of individual decompensating events in stable decompensated outpatients with cirrhosis using a multi-center cohort
66. Gender differences in the patient-reported outcomes and perception of ascites burden amongst outpatients with decompensated cirrhosis and ascites
67. Further decompensation as a new prognostic stage in cirrhosis. Results of a large multicenter cohort study supporting Baveno VII statements
68. Emerging concepts in the care of patients with cirrhosis and septic shock
69. Impact of Treatment of Non-bleeding Complications of Cirrhosis on the Risk of Variceal Bleeding
70. Effect of Current Therapies Aimed at Preventing Variceal Rebleeding on Other Complications of Cirrhosis
71. Issues in Trial Design and Areas Needing Further Research
72. Secondary Prophylaxis in Special Patient Populations
73. Introduction and Survey Results
74. Prevention of Variceal Rebleeding: Stratifying Risk and Individualizing Care
75. Primary and secondary prophylaxis of esophageal variceal bleeding
76. Hepatic Encephalopathy Is Associated With Mortality in Patients With Cirrhosis Independent of Other Extrahepatic Organ Failures
77. Gastroesophageal Variceal Bleeding Management
78. Esophageal Varices
79. Natural History of Cirrhosis
80. The Impact of Albumin Use on Resolution of Hyponatremia in Hospitalized Patients With Cirrhosis
81. Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis
82. Acute Kidney Injury in Patients with Cirrhosis
83. Corrigendum to “Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites”
84. Machine learning liver histology scores correlate with portal hypertension assessments in nonalcoholic steatohepatitis cirrhosis
85. AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF)
86. Congenital Hepatic Vascular Malformations
87. Management: Cirrhotic Portal Hypertension
88. Consensus Statements: Preventing Recurrent Variceal Hemorrhage and Other Decompensating Events
89. Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem
90. Reply to Risk Stratification in Acute Variceal Bleeding: Child-Pugh Versus Model for End-stage Liver Disease
91. Ascites
92. Contributors
93. Ascites and Hyponatremia
94. Management of Portal Hypertension
95. The Role of Medical Therapy for Variceal Bleeding
96. Long-term Use of Antibiotics and Proton Pump Inhibitors Predict Development of Infections in Patients With Cirrhosis
97. Endovascular Assessment of Liver Hemodynamics in Patients with Cirrhosis Complicated by Portal Hypertension
98. Plasma Proteomic Profiling Illustrates Endothelial and Complement Signature in Patients with Alcohol-Associated Cirrhosis
99. Role of Oral Health, Frailty, and Minimal Hepatic Encephalopathy in the Risk of Hospitalization: A Prospective Multi-Center Cohort of Outpatients With Cirrhosis
100. “Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH”: Comment from Hartmann et al.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.